Stem cells hold remarkable patient-centric promise, though tumorigenicity risks, reprogramming inefficiencies, and inconsistent characterization standards continue to challenge their safe and large-scale clinical implementation.
Microtiter plate readers, liquid handlers, and robotic platforms are actively transforming life science laboratories. Across screening and diagnostics, their benefits primarily affect productivity, reproducibility, and data quality.
Manual errors in cell culture carry significant financial consequences. Automation delivers measurable gains in robustness, quality control, and scalability for CGT manufacturing.
Scaling-out is transforming personalized therapies by replacing the dominant scale-up logic, enabling clinical manufacturing that is aligned with biology-driven design and patient-centered production timelines.
Fully closed systems using aseptic connectors enable sterile, flexible bioprocessing, lowering batch failure, simplifying GMP workflows, and support scalable manufacturing in advanced therapies.
CGT manufacturing faces costs and capacity limits. Strategic adaptation of automated cell culture systems can improve scalability and efficiency, extending the change onto additional aspects of the industry.
Closed systems in cell culture manufacturing reduce contamination risk, improve GMP compliance, and enable scalable manufacturing, addressing cost, variability, and regulatory barriers persistent in the advanced therapy landscape.
Cell therapy success increasingly depends on automation, enabling scalable, reproducible manufacturing, reducing regulatory risk, and improving patient access to advanced therapies across GMP settings.
Advanced Therapy Medicinal Products promise transformative medicine, though regulatory complexities, manufacturing variability, and fragmented reimbursement continue to limit patient access across Europe despite latest scientific progress.
See how leveraging LCA and Scope 3 emissions accounting enables applicable quantification of greenhouse gas footprints, empowering researchers to design more sustainable bioprocesses and products.
